Concepedia

Karen Dunn

KD

20

Publications

1.8K

Citations

14

H-Index

1984

Active since

Affiliations

University of Glasgow(Current)

Cancer Research UK Scotland Institute

University of Edinburgh

MRC Centre for Regenerative Medicine

Blood Cancer UK

Karen Dunn is an author at University of Glasgow specializing in medicine, cell biology, and immunology.

ORCID

Top concepts

Publications per year

1984–2024

20

Publications

20

Targeting mitochondrial oxidative phosphorylation eradicates therapy-resistant chronic myeloid leukemia stem cells

Elodie M. Kuntz, Pablo Baquero, Alison M. Michie et al. · Nature Medicine · 2017 · 543 citations · Full text

, , +9

Brusatol provokes a rapid and transient inhibition of Nrf2 signaling and sensitizes mammalian cells to chemical toxicity—implications for therapeutic targeting of Nrf2

Ian M. Copple, Holly K. Bryan, George T. Edge et al. · Free Radical Biology and Medicine · 2014 · 227 citations · Full text

Dual targeting of p53 and c-MYC selectively eliminates leukaemic stem cells

Sheela A. Abraham, Lisa Hopcroft, Emma Carrick et al. · Nature · 2016 · 223 citations · Full text

, , +11

Epigenetic Reprogramming Sensitizes CML Stem Cells to Combined EZH2 and Tyrosine Kinase Inhibition

Mary T. Scott, Koorosh Korfi, Peter Saffrey et al. · Cancer Discovery · 2016 · 131 citations · Full text

Neonatal T-cell tolerance to minimal immunogenic peptides is caused by clonal inactivation

Guy Gammon, Karen Dunn, Nilabh Shastri et al. · Nature · 1986 · 121 citations

, , +10

Rows per page

1–5 of 20